Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial

By afschroeder • November 4, 2025

Lookstein RA, Konstantinides SV, Weinberg I, Dohad SY, Rosol Z, Kopeć G, Moriarty JM, Parikh SA, Holden A, Channick RN, McDonald B, Nagarsheth KH, Yamada K, Rosovsky RP; STORM-PE Trial Investigators. Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial. Circulation. 2025 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.077232. Epub ahead of print. PMID: 41183181.

Tags: Cardiology/Epi, Publications, Pulmonary, Critical Care & Sleep Medicine

Atrial Fibrillation and Cancer: Bidirectional Relationship and Potential for Personalized Care

Grewal US, Byer SH, Mahajan S, Sheth AR, Beedupalli K, Fradley MG, Yang EH, Russo AM, Asnani A, Dominic P. Atrial Fibrillation and Cancer: Bidirectional[...]

Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with inherited cardiomyopathies

Sarkar A, Pisciotti SL, Tapias C, Assis F, Tandri H, Wang J, Chrispin J, Syed F, Yanagawa J, Lee J, Bradfield JS, Shivkumar K, Saenz[...]

Stellate ganglion modulation: An old therapy with a new twist for treatment of ventricular arrhythmias

Avasthi S, Vaseghi M. Stellate ganglion modulation: An old therapy with a new twist for treatment of ventricular arrhythmias. Indian Pacing Electrophysiol J. 2025 Oct[...]